Westmead Dermatology
Striving towards disease-free skin
The Eureka Prizes are the “Oscars” of Science in Australia. ACEMID (ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis) was one of the three finalists for the Aspire Scholarship Eureka Prize for Excellence in Interdisciplinary Scientific Research. The Extinction vs Adaption Team and the Octopus and Ice Sheet Team were the other two …
There are lots of discussions of how we should name this group of skin conditions, with different countries and clinicians supporting one name or another. Naming things is very important. It help us to frame the problem, to recognise what is in it and what is not, and to perform better research. But the tools …
We have recently open our clinical trials for recruitment. We had to close recruitment again during the peak of the COVID pandemic and we modified our protocols to safely continue with all patients on trials. But skin conditions do not disappear, and patients continue suffering from their skin diseases. The teams at Westmead Dermatology (Westmead …
Westmead Hospital is one of sites for this amazing project and Prof Pablo Fernandez-Peñas is the NSW Lead for the ACRF ACEMID. The project will install a Vectra WB360 whole body 3D imaging system in the Department of Dermatology (Westmead Hospital). The system will be used for a number of research projects in subjects with …
Recently, an open competitive grant application by members of the CTSR (Prof Pablo Fernandez-Penas as PI and Dr Ali Azimi as Sub-PI) was approved for funding by Pfizer through its Global Medical Grants Programme. The study is a 1.5 years long Phase IV clinical trial involving the investigation of the effect of nonsteroidal phosphodiesterase 4 …
Hidradenitis suppurativa is an inflammatory skin disease affecting apocrine bearing areas such as the axillae and groin, characterised by recurrent discharging abscesses and sinuses, inflammatory nodules and scarring. The Westmead Dermatology Department is currently recruiting patients with HS for a phase 2 study evaluating the efficacy of bimekizumab in patients with moderate to severe hidradenitis …
The report on our study looking at the optimal delivery of phototherapy education to patients was published this week in the British Journal of Dermatology. Summary: This study aimed to improve the phototherapy safety knowledge of patients starting treatment. We designed a self-directed tablet-based education session, which covered the key phototherapy safety and responsibility messages …
Written by Dr Shelley Ji Eun Hwang High Risk Melanoma Clinic is currently recruiting patients in Westmead Hospital. If the patient meets the following inclusion criteria (any of these): 2 x primary invasive melanomas 1 x primary invasive melanoma + Family history (≥ 3 first or second degree relatives) 1 x primary invasive melanoma + …
Our high risk melanoma clinic has recruited 21 patients till date. We are looking forward to recruit more in the future. Any person with a history of 2 or more melanomas, 1 melanoma and positive family history or dysplastic nevus syndrome is welcome to participate in the trial. Our experience so far has been very …
Aside from melanoma, we are also involved with research into non-melanoma skin cancer (NMSC) prevention and management. NMSC are the most common type of cancers in Australia and while most are not life threatening, it is an important condition which accounts for a high rate of hospitalisations in Australia each year. As part of our …
